Mesoblast (MESO) EBT Margin Growth (3y) (2017 - 2023)
Powered by 
Analysis
Mesoblast (MESO) EBT Margin Growth (3y) (2017 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -484.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 132.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 6,691.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2,054.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8,006.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 9,980.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -5,319.00 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 31,363.00 |
| 10 | Mesoblast | 2.24 Bn | 2.14 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | -79,794.00 |
| Dec 31, 2022 | -20,147.00 |
| Sep 30, 2022 | -108,351.00 |
| Jun 30, 2022 | 925,424.00 |
| Mar 31, 2022 | 111,423.00 |
| Dec 31, 2021 | 73,293.00 |
| Sep 30, 2021 | -45,814.00 |
| Jun 30, 2021 | 1.03 Mn |
| Mar 31, 2021 | 90,589.00 |
| Dec 31, 2020 | -107,120.00 |
| Sep 30, 2020 | -109,173.00 |
| Mar 31, 2020 | 126,550.00 |
| Dec 31, 2019 | 326,472.00 |
| Sep 30, 2019 | 575,473.00 |
| Jun 30, 2019 | -108,792.00 |
| Mar 31, 2019 | -166,577.00 |
| Dec 31, 2018 | -91,275.00 |
| Sep 30, 2018 | 8,135.00 |
| Jun 30, 2018 | -55,336.00 |
| Mar 31, 2018 | -177,128.00 |